Neoplasia/BPH

	The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollment. Urology Lotan P, Wentland AL, Shapiro DD, Smith MR, Roadman DF, Allen GO, Jarrard DF, Nichols K, Risk MC, Richards KA, Koehne EL, Jason Abel E. PMID: 41825786 [PubMed - as supplied by publisher]
	Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: a virtuous circle between oncologists and organ specialists. Crit Rev Oncol Hematol Sabbatini R, Cosmai L, De Leo S, Ianiro G, Luppi F, Spallarossa P, Vacchi C, Porta C. PMID: 41825579 [PubMed - as supplied by publisher]
	Advances in Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer. Crit Rev Oncol Hematol Tang Y, Wang L, Liu H, Zhu Q, Xu C, Zeng H, Chen J. PMID: 41825577 [PubMed - as supplied by publisher]
	The effect of opium consumption on prostate cancer among Iranian patients: A retrospective analytical study. Medicine (Baltimore) Mohammadi R, Mirzaei M, Tajik Ghanbari A, Mirolyaie A, Abbasi M, Ranjbaran S. PMID: 41824892 [PubMed - indexed for MEDLINE]
	Impact of physiological ability and surgical stress score on postoperative complications in patients undergoing surgery for non-muscle-invasive bladder cancer. Medicine (Baltimore) Bai J. PMID: 41824818 [PubMed - indexed for MEDLINE]
	Clinical validity of circulating tumor DNA as a diagnostic biomarker for prostate cancer: a systematic review. Cancer Epidemiol Biomarkers Prev De Vrieze M, Zhang N, Seibold P, Gerhäuser C, Albers P, Krilaviciute A. PMID: 41824537 [PubMed - as supplied by publisher]
	Lymphatic mapping and sentinel lymph node biopsy in urinary bladder cancer: A SPECT/CT-based experience. Ann Nucl Med Saber Tanha A, Sadeghi R, Ghorbani H, Soltani S, Aghaee A, Zarifmahmoudi L, Sadri K, Mehrad-Majd H, Asl Zare M. PMID: 41824256 [PubMed - as supplied by publisher]
	Selective Cell Size MRI for the Diagnosis and Grading of Clinically Significant Prostate Cancer: A Feasibility Study. NMR Biomed Cheng H, Lu J, Liu M, Zhang W, Zhu J, Chen M, Wu D, Li C. PMID: 41823388 [PubMed - indexed for MEDLINE]
	Do patterns of perineural invasion improve risk stratification in prostate cancer? A narrative review. Histol Histopathol Miyamoto H. PMID: 41823190 [PubMed - as supplied by publisher]
	Diagnostic accuracy and reliability of VI-RADS in assessing muscle invasion in bladder cancer: Insight from a prospective tertiary care study. Urologia Shukla A, Hiralal, Raj H, Surekha S, Singh UP. PMID: 41823129 [PubMed - as supplied by publisher]
	A narrative review of the current state of circulating tumor cells in prostate cancer diagnostic. Hell Urol Vovdenko S, Bazarkin A, Morozov A, Golan S, Babaevskaya D, Singla N, Baniel J, Brill B, Moreno Sierra J, Gomez Rivas J, Enikeev D. PMID: 41822810 [PubMed]
	Kidney-Sparing Approaches in Upper Tract Urothelial Cancer: A Narrative Review. Cureus Kefalas C, Datseris N, Sitaridis K, Mourtzilas E, Papalakis A. PMID: 41822654 [PubMed]
	Application of carbonic anhydrase IX-targeted radiopharmaceuticals in the diagnosis and treatment of clear cell renal cell carcinoma (Review). Oncol Lett Wang M, Li Y, Yang W, Liu B. PMID: 41822559 [PubMed]
	Deep learning-based detection and segmentation of osseous metastatic prostate cancer lesions on computed tomography. Eur J Radiol Artif Intell Pawan SJ, Rich JM, Malewar S, Patel D, Muellner M, Hwang D, Lei X, Cen S, Triche T, Goldkorn A, Mohamed P, Oberai A, Duddalwar V. PMID: 41822381 [PubMed]
	Functional and Survival Outcomes of Partial Versus Radical Nephrectomy in Renal Cell Carcinoma Patients With Pre-Existing Chronic Kidney Disease: A Real-World Study. World J Oncol Thai LK, Luu VQ, Thai SM. PMID: 41822317 [PubMed]
	Muscle size and muscle fat infiltration in patients with newly diagnosed prostate cancer: a case-control study. Front Oncol Wang C, Wang H, Yu Y, Yang X, Wang Y, Zhang K, Sun S, Wu L, Fang D, Li H, Yang Y, Chen X, Bi S, Wen H. PMID: 41821899 [PubMed]
	Body mass index and prostate cancer incidence: a comprehensive systematic review. Front Oncol Myers D, Chissum Lagos D, Zapata I, Hwang C. PMID: 41821886 [PubMed]
	The prognostic impact of systemic inflammation and nutritional indicators on targeted therapy for renal cell carcinoma: a systematic review and meta-analysis. Front Nutr Xiao Y, Dai Y, Zhong X, Zhang L, Xie R, Zhou Q, Liang W, Sun X, Yang M, Zou Z, Wang Y, Li H, Niu T. PMID: 41821864 [PubMed]
	Disulfidptosis and androgenic cancers: from molecular mechanisms to clinical applications and future translational research. Front Endocrinol (Lausanne) Wang X, Zhao J, Li Q, Chang J, Zhao W, Xing X. PMID: 41821736 [PubMed - indexed for MEDLINE]
	Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma. Ann Med He DL, Zhu FF, Wang J, Zhu SW, Hou SS. PMID: 41821478 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186316

Page 1 of 9316



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy